-
In this newsletter, we discuss legal news which affects the pharmaceutical and pharmacy sector. The Commission’s proposal on the Critical Medicines Act will hopefully provide tools for member states to avoid supply chain issues in relation to critical medicines. Interpretations by the Court of Justice of the European Union assist market players to navigate in […]
-
On 17 April 2025, the Parliament amended the Law on the Establishment of Restrictive Measures Regarding Military Aggression against Ukraine. The aforementioned law is yet to be signed by the President. Still, it is expected to be done shortly, thus allowing the new statutory restriction to enter into force starting on 3 May 2025. New […]
-
Yesterday, the Baltic Deals of the Year were announced at the Baltic M&A and Private Equity Forum 2025 in Tallinn. The winners were Finnish-based Mehiläinen, Lithuania’s Vinted and Invalda INVL Group, and Estonia’s Elenger, part of the Infortar group. Award Winners 2025 The Baltic M&A Deal of the Year is Mehiläinen’s acquisition of InMedica. The […]
-
We advised a London-based venture capital fund in investing EUR 2 million in the Estonian defence industry company Frankenburg Technologies. Founded just last year, Frankenburg Technologies plans to use the funds raised for further development of anti-aircraft missiles. Blossom Capital invests in the future of Estonian defence technology “Frankenburg’s goal is to develop technology that […]
-
We advised Eiffel Investment Group on a EUR 20 million debt financing agreement with Envolve Capital (formerly Modus Asset Management), one of the leading investment fund management companies specializing in energy transition in the Baltics and Central Europe. The financing will support the construction and commissioning of a 177 MW portfolio of solar and wind […]
